Healthcare AI firm Qure.ai has appointed Mihir Bhanushali as Executive Vice President, Global Health
CE DESK 
Healthcare AI firm Qure.ai has appointed Mihir Bhanushali as Executive Vice President, Global Health, tasking him with scaling the company’s AI-powered diagnostic and care-delivery solutions across low- and middle-income countries (LMICs). Bhanushali will lead Qure.ai’s next phase of growth in Africa, Southeast Asia, South Asia and Latin America, with a focus on infectious diseases such as tuberculosis and HIV, as well as frontline health-system deployments.
Bhanushali joins from Freshworks, where he served as Senior Director, Global Sales, building and leading international sales teams and commercial operations. Prior to that, he held leadership roles at Rippling and Whatfix, spanning sales, go-to-market strategy and commercial transformation, and has experience scaling high-growth B2B businesses across multiple geographies. On LinkedIn, he notes a track record of closing $1M+ ARR deals and building GTM playbooks for SaaS and enterprise tech.
“I’m delighted to welcome Mihir Bhanushali to Qure.ai as our Executive Vice President, Global Health. Improving healthcare access in low- and middle-income countries is at the core of our mission, and Mihir brings a wealth of experience in scaling high-growth businesses across international markets. His expertise in building commercial engines and driving go-to-market strategy will be invaluable as we expand our footprint in Africa, Southeast Asia, South Asia and Latin America.”
— Prashant Warier, Founder & CEO, Qure.ai
Founded in 2016, Qure.ai has built machine-learning and AI solutions that can read and interpret medical images such as X-rays, CT scans and ultrasounds in under a minute, supporting screening and triage for conditions including TB, HIV-related complications and other priority diseases. With Bhanushali’s appointment, the company is signalling a shift from product-led growth to a more structured, market-by-market commercial expansion, aiming to embed its tools deeper into public and private health systems where speed, accuracy and cost matter most.
